// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Epidemiological burden of moderate-to-very severe COPD: a systematic literature review

Neha Sharma - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

London-wide variation in ambulance activity for paediatric asthma

Duke Razon - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Is the association between physical activity and lung function due to reverse causation? An application of exploratory and causal approaches

Annabelle Bdard - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR)

John Busby - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Risk of respiratory-related death in individuals with COPD and asthma: a competing risk analysis

Alicia Gayle - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Prognostic significance of respiratory symptoms in individuals with preserved pulmonary function without known airway disease

Yunus olak - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

N/A

Lung function up to adolescence and residential greenspace

Elaine Fuertes - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Late Breaking Abstract - Ultraviolet radiation and lung function in aging women: A European multi-centre study (ECRHS)

Kai Triebner - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ergocalciferol

Determinants of long-term changes in ADO prognostic score in UK COPD primary care patients: results from The Health Improvement Network

Spencer Keene - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

COPD phenotypes not linked to increased risk of coronary heart disease

Christina Due Svendsen - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Coronary Artery Disease

N/A

Missed opportunity to manage COPD in patients hospitalised for heart failure

Claudia Gulea - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Congestive heart failure

N/A

A study of burnout and professional fulfilment among respiratory physicians (RP) in United Kingdom (UK)

Shahbaz Piracha - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Where and by whom do patients want to be cared for: Preferences for the Breathlessness Support Service in England?

Deokhee Yi - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective

J. Mark FitzGerald - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

budesonide + formoterol fuma

The impact of a new recruitment strategy to improve recruitment of participants to research studies

Michelle Bourne - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Withdrawal of high-dose inhaled corticosteroids in COPD patients with mild or moderate airflow limitation: a feasibility study in primary care

Patrick T. White - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Deprescribing of inhaled corticosteroids in patients with COPD with mild or moderate airflow limitation: what do patients think?

Gill Gilworth - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK

Mukesh Singh - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Do interventions that address health literacy needs improve self-management among people with asthma? A systematic review

Hani Syahida Salim - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Asthma patients’ views and experiences of self-management in Malaysia: a qualitative study

Wen Ming Koh - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved